From planta to pharma with glycosylation in the toolbox

Trends in Biotechnology

Volumn 25, Issue 7, 2007, Pages 317-323

  Saint Jore Dupas, Claude ^a   Faye, Loïc ^a   Gomord, Véronique ^a  

^a GDR 2590   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; DRUG THERAPY; PLANTS (BOTANY);

HUMAN THERAPY; HUMANIZATION; N-GLYCOSYLATION;

GLYCOSYLATION;

AMINO ACID; ANTIBODY; CANCER ANTIBODY; GLUCOSYLCERAMIDASE; GLYCAN; GLYCOPROTEIN; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN A1; MACROGOL; VACCINE;

CELL LINE; CHO CELL; DRUG ACTIVITY; ENDOPLASMIC RETICULUM; GAUCHER DISEASE; GENE EXPRESSION SYSTEM; GENETIC ENGINEERING; GLYCOSYLATION; HODGKIN DISEASE; HUMAN; IN VITRO STUDY; KNOCKOUT GENE; NONHUMAN; PHYSCOMITRELLA; PLANT; PLANT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSGENIC CROP; TRANSGENIC PLANT;

GLYCOSYLATION; GLYCOSYLTRANSFERASES; PHARMACEUTICAL PREPARATIONS; PLANTS; PLANTS, GENETICALLY MODIFIED; POLYSACCHARIDES;

EID: 34250346068     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2007.04.008     Document Type: Review

References (60)

1. Spiro R.G. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12 (2002) 43-56
2. Galili U., et al. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 82 (1993) 2485-2493
3. Higashi H., et al. Antigen of 'serum sickness' type of heterophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid. Biochem. Biophys. Res. Commun. 79 (1977) 388-395
4. Chenu S. Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy. Biochim. Biophys. Acta 1622 (2003) 133-144
5. Gomord V., and Faye L. Post-translational modification of therapeutic proteins in plants. Curr. Opin. Plant Biol. 7 (2004) 171-181
6. Faye L., et al. Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine 23 (2005) 1770-1778
7. Lerouge P., et al. N-Glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol. 38 (1998) 31-48
8. Aalberse R.C., et al. Cross-reactions between vegetable foods, pollen and bee venom due to IgE antibodies to a ubiquitous carbohydrate determinant. Int. Arch. Allergy Appl. Immunol. 66 (1981) 259-260
9. Aalberse R.C., et al. Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom. J. Allergy Clin. Immunol. 68 (1981) 356-364
10. Aalberse R.C., et al. Cross-reactivity of IgE antibodies to allergens. Allergy 56 (2001) 478-490
11. Bardor M., et al. Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1,3)-fucose and core xylose. Glycobiology 13 (2003) 427-434
12. Jin C., et al. Immunoglobulin G specifically binding plant N-glycans with high affinity could be generated in rabbits but not in mice. Glycobiology 16 (2006) 349-357
13. van Ree R., and Aalberse R.C. Specific IgE without clinical allergy. J. Allergy Clin. Immunol. 103 (1999) 1000-1001
14. Ma J.K., et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4 (1998) 601-606
15. Zeitlin L., et al. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat. Biotechnol. 16 (1998) 1361-1364
16. Pagny S., et al. Protein recycling from the Golgi apparatus to the endoplasmic reticulum in plants and its minor contribution to calreticulin retention. Plant Cell 12 (2000) 739-756
17. Navazio L., et al. Primary structure of the N-linked carbohydrate chains of calreticulin from spinach leaves. Glycoconj. J. 13 (1996) 977-983
18. Navazio L., et al. Functional conservation of calreticulin in Euglena gracilis. J. Eukaryot. Microbiol. 45 (1998) 307-313
19. Gomord V., et al. The C-terminal HDEL sequence is sufficient for retention of secretory proteins in the endoplasmic reticulum (ER) but promotes vacuolar targeting of proteins that escape the ER. Plant J. 11 (1997) 313-325
20. Sriraman R., et al. Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core α(1,3)-fucose residues. Plant Biotechnol. J. 2 (2004) 279-287
21. Petruccelli S., et al. A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnol. J. 4 (2006) 511-527
22. Wright A., and Morrison S.L. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J. Immunol. 160 (1998) 3393-3402
23. Ko K., et al. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8013-8018
24. Schumacher C.L. Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens. Vaccine 10 (1992) 754-760
25. Friedman B., et al. A comparison of the pharmacological properties of carbohydrate-remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease. Blood 93 (1999) 2807-2816
26. Downing W.L., et al. Synthesis of enzymatically active human α-l-iduronidase in Arabidopsis cgl (complex glycan-deficient) seeds. Plant Biotechnol. J. 4 (2006) 169-181
27. Strasser R., et al. Generation of Arabidopsis thaliana plants with complex N-glycans lacking β1,2-linked xylose and core α1,3-linked fucose. FEBS Lett. 561 (2004) 132-136
28. Cox K.M., et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol. 24 (2006) 1591-1597
29. Koprivova A., et al. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol. J. 2 (2004) 517-523
30. Niwa R., et al. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J. Immunol. Methods 306 (2005) 151-160
31. Ferrara C., et al. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous β1,4-N-acetylglucosaminyl transferase III and Golgi α-mannosidase II. Biotechnol. Bioeng. 93 (2006) 851-861
32. Shields R.L., et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcγ RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277 (2002) 26733-26740
33. Shinkawa T., et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278 (2003) 3466-3473
34. Erbayraktar S. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6741-6746
35. Kompella A., and Lee V. Pharmacokinetics of peptide and protein drugs. In: Lee V. (Ed). Peptide and Protein Drug Delivery (1991), Marcel Dekker 391-484
36. Bakker H., et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2899-2904
37. Cabanes-Macheteau M., et al. N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology 9 (1999) 365-372
38. Palacpac N.Q., et al. Stable expression of human β1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4692-4697
39. Misaki R., et al. Plant cultured cells expressing human β1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans. Glycobiology 13 (2003) 199-205
40. Fujiyama K., et al. In vivo conversion of a glycan to human-compatible type by transformed tobacco cells. Biochem. Biophys. Res. Commun. 289 (2001) 553-557
41. Bardor M., et al. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant Biotechnol. J. 1 (2003) 451-462
42. Choi B.K., et al. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5022-5027
43. Saint-Jore-Dupas C., et al. Plant N-glycan processing enzymes employ different targeting mechanisms for their spatial arrangement along the secretory pathway. Plant Cell 18 (2006) 3182-3200
44. Pagny S., et al. Structural requirements for Arabidopsis β1,2-xylosyltransferase activity and targeting to the Golgi. Plant J. 33 (2003) 189-203
45. Bakker H., et al. An antibody produced in tobacco expressing a hybrid β-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7577-7582
46. Seveno M., et al. Glycoprotein sialylation in plants?. Nat. Biotechnol. 22 (2004) 1351-1352
47. Zeleny R., et al. Sialic acid concentrations in plants are in the range of inadvertent contamination. Planta 224 (2006) 222-227
48. Jarvis D.L. Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production. Virology 310 (2003) 1-7
49. Wee E.G., et al. Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 10 (1998) 1759-1768
50. Misaki R., et al. Expression of human CMP-N-acetylneuraminic acid synthetase and CMP-sialic acid transporter in tobacco suspension-cultured cell. Biochem. Biophys. Res. Commun. 339 (2006) 1184-1189
51. Paccalet T., et al. Engineering of a sialic acid synthesis pathway in transgenic plants by expression of bacterial Neu5Ac-synthesizing enzymes. Plant Biotechnol. J. 5 (2007) 16-25
52. Kieliszewski M.J., and Shpak E. Synthetic genes for the elucidation of glycosylation codes for arabinogalactan-proteins and other hydroxyproline-rich glycoproteins. Cell. Mol. Life Sci. 58 (2005) 1386-1398
53. Karnoup A.S., et al. O-Linked glycosylation in maize-expressed human IgA1. Glycobiology 15 (2005) 965-981
54. Kabat E.A., et al. Sequences of Proteins of Immunological Interest. 5th ed. (1991), US Department of Health and Human Services pp. 663-681
55. Kerr M.A. The structure and function of human IgA. Biochem. J. 271 (1990) 285-296
56. Mattu T.S., et al. The glycosylation and structure of human serum IgA1, Fab and Fc regions and the role of N-glycosylation on Fc α-receptor interactions. J. Biol. Chem. 273 (1998) 2260-2272
57. Klieliszewski et al. Methods of producing peptides/proteins in plants and peptides/proteins produced thereby, United States Patent 20060026719
58. Showalter A.M. Arabinogalactan proteins: structure, expression and function. Cell. Mol. Life Sci. 58 (2001) 1399-1417
59. Ashwell G., and Harford J. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51 (1982) 531-554
60. Harford J., and Ashwell G.G. Immunological evidence for the transmembrane nature of the rat liver receptor for asialoglycoproteins. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 1557-1561